Biotech Values

[DewDiligence]

>MDCO's counsel should be fired anyway maybe the ceo too.<

Actually, the old CEO was fired—not for flubbing the patent extension but rather for sexual harassment of a coworker.

>Anyone know if the new bill would make patent extensions longer than 5 years?<

The possible bill mentioned in today’s MDCO SEC filing does not alter the formula for Hatch-Waxman patent extensions—it merely allows the PTO to overlook a clerical error such as the one that MDCO made.

>In europe its 10 years.<

The 10-year period you are referring to is the statutory period of data exclusivity in the EU for a new drug, which is entirely separate from patent protection. Regards, Dew